Related Experiment Videos
[Treatment of malignant otitis externa]
M González Ortín1, E López Meseguer, A Estaca Jiménez
1Hospital General de Murcia, Departamento de Otorrinolaringologia, Facultad de Medicina, Universidad de Murcia.
Abstract:
Though rare the malignant otitis externa must be borne in mind because in its precocious diagnosis is based the success of the management. Elderly people, diabetics and immunodepressed are especially exposed. The CAT is basic in order to detect the spreading of the process. The patient being admitted at a Medical center, the antibiotherapy started at once with Ceftazidine, 2 g every 12 hours via i.v. The exeresis of the e.e.ca proves sometimes necessary after control of the infection. This procedure assures the healing and prevent the recurrences some times seen. But when infection disappears owing to the success of the antibiotherapy in 2-3 weeks; the culture for Pseudomonas is negative 3 weeks later; and the previous CAT showed no spreading to the tympanal bone, the surgery must be discarded. The process is considered over when the culture for Pseudomonas aeruginosa is negative, but review of the patients is compulsory at least during half a year.
Insights
Malignant otitis externa requires prompt diagnosis and treatment, especially in elderly, diabetic, or immunocompromised patients. Early intervention with antibiotics and imaging can prevent the need for surgery.
Area of Science:
- Otolaryngology
- Infectious Diseases
Background:
- Malignant otitis externa (MOE) is a rare but serious infection.
- Prompt diagnosis and management are crucial for successful outcomes.
- Elderly, diabetic, and immunocompromised individuals are at higher risk.